Esperion Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Esperion Therapeutics, Inc. reported Common Stock Shares Outstanding of 27.50 million shares for the year ending 2019.

  • Esperion Therapeutics, Inc. showed an increase of +2.5% in Common Stock Shares Outstanding from 2018 to 2019.
  • This data is from Esperion Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 23, 2021.
  • XBRL data for this metric is available from 2012 to 2019 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2012 to 2019), Esperion Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 7,836.4%.
  • Historical annual values: Fiscal year 2019: 27.50 million shares | Fiscal year 2018: 26.82 million shares | Fiscal year 2017: 26.30 million shares | Fiscal year 2016: 22.56 million shares | Fiscal year 2015: 22.52 million shares | Fiscal year 2014: 20.34 million shares | Fiscal year 2013: 15.34 million shares | Fiscal year 2012: 346,478 shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: